| Hauptseite > Publikationsdatenbank > Cerebrospinal Fluid Analysis Post–COVID-19 Is Not Suggestive of Persistent Central Nervous System Infection | 
| Journal Article | FZJ-2021-04101 | 
  ;   ;   ;   ;   ;   ;   ;   ;   ;   ;   ;   ;   ;  
2022
Wiley-Blackwell
Hoboken, NJ
This record in other databases:  
   
    
Please use a persistent id in citations: http://hdl.handle.net/2128/29661 doi:10.1002/ana.26262
Abstract: This study was undertaken to assess whether SARS-CoV-2 causes a persistent central nervous system infection. SARS-CoV-2–specific antibody index and SARS-CoV-2 RNA were studied in cerebrospinal fluid following COVID-19. Cerebrospinal fluid was assessed between days 1 and 30 (n = 12), between days 31 and 90 (n = 8), or later than 90 days (post–COVID-19, n = 20) after COVID-19 diagnosis. SARS-CoV-2 RNA was absent in all patients, and in none of the 20 patients with post–COVID-19 syndrome were intrathecally produced anti–SARS-CoV-2 antibodies detected. The absence of evidence of SARS-CoV-2 in cerebrospinal fluid argues against a persistent central nervous system infection as a cause of neurological or neuropsychiatric post–COVID-19 syndrome. ANN NEUROL 2022;91:150–157
 ;
 ;  ;
 ;  ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; Current Contents - Life Sciences ; DEAL Wiley ; Ebsco Academic Search ; Essential Science Indicators ; IF >= 10 ; JCR ; Nationallizenz
 ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; Current Contents - Life Sciences ; DEAL Wiley ; Ebsco Academic Search ; Essential Science Indicators ; IF >= 10 ; JCR ; Nationallizenz ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
 ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
|   | The record appears in these collections: | 
 PDF
 PDF PDF
 PDF Fulltext by OpenAccess repository
Fulltext by OpenAccess repository